Cellebrite DI reported Q2 earnings with an EPS of $0.11, beating estimates, but missed revenue forecasts at $131.14 million due to delays in large deals. The company lowered its full-year revenue outlook as a result. Despite this, Cellebrite maintains strong financial health with a low debt-to-equity ratio of 0.045. A leadership transition is underway with Shiven Ramji appointed as the new CEO, focusing on expanding cloud and AI capabilities.
Greg Abel, Warren Buffett's successor at Berkshire Hathaway, reduced the company's investment in Bank of America by $1.7 billion. At the same time, he increased the stake in Delta Air Lines by $1.6 billion. This shift in portfolio allocation highligh...
TruBridge, Inc. disclosed errors in its financial statements for 2023 and 2024, causing a delay in its 2025 annual report and a 10.5% stock price drop. The errors involve revenue recognition, contract costs, stock-based compensation, and software dev...
In June 2026, President Donald Trump executed more than 1,000 stock trades, including purchases in SpaceX shortly after its IPO and multiple transactions in tech and defense companies like Palantir. The largest trade was a sale of Vanguard ETF shares...
Bitcoin experienced a sharp flash crash, dropping over 6% after rising more than 25% this week and nearly touching $80,000. Despite this, BTC remains up over 21% for the week, indicating a healthy correction rather than a major crash. Strong inflows ...
XRP is experiencing its biggest weekly gain since late 2024, rising between 30% and 67% after the US Treasury announced it would double its long-term bond buyback program from $2 billion to $4 billion per operation starting September 9. This move has...
